Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor resistance mechanisms and their consequences on γδ T cell activation
Daniela Wesch, Dieter Kabelitz, Hans‐Heinrich Oberg
Immunological Reviews (2020) Vol. 298, Iss. 1, pp. 84-98
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 105
Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Zhifei Gao, Yifeng Bai, Anqi Lin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 65
γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells
Kok Fei Chan, Jessica Da Gama Duarte, Simone Ostrouska, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
A bispecific nanomodulator to potentiate photothermal cancer immunotherapy
Lei Zhou, Bing Feng, Hao Wang, et al.
Nano Today (2022) Vol. 44, pp. 101466-101466
Closed Access | Times Cited: 42
Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation–Cancer Interface
Trevor W. Stone, Richard Williams
Cancers (2023) Vol. 15, Iss. 11, pp. 2895-2895
Open Access | Times Cited: 27
Gamma/delta T cells as cellular vehicles for anti-tumor immunity
Chelsia Qiuxia Wang, Pei Yu Lim, Andy Hee‐Meng Tan
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 13
Toxic reactive oxygen species enhanced chemodynamic therapy by copper metal-nanocellulose based nanocatalysts
Chaoqun You, Like Ning, Zheng Zhang, et al.
Carbohydrate Polymers (2022) Vol. 289, pp. 119432-119432
Closed Access | Times Cited: 33
Heterogeneity induced GZMA-F2R communication inefficient impairs antitumor immunotherapy of PD-1 mAb through JAK2/STAT1 signal suppression in hepatocellular carcinoma
Yuxue Gao, Qingguo Xu, Xinqiang Li, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 31
Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer
Pauline Weimer, Jasmin Wellbrock, Tabea Sturmheit, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 964-964
Open Access | Times Cited: 31
Effective γδ T‐cell clinical therapies: current limitations and future perspectives for cancer immunotherapy
Isabella A. Revesz, Paul Joyce, Lisa M. Ebert, et al.
Clinical & Translational Immunology (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 5
Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma
Franziska Brauneck, Pauline Weimer, Julian Schulze zur Wiesch, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 30
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments
Sylvain Nguyen, Mathieu F. Chevalier, Sulayman Benmerzoug, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 8, pp. e004880-e004880
Open Access | Times Cited: 19
Stimulatory and inhibitory activity of STING ligands on tumor-reactive human gamma/delta T cells
Ruben Serrano, Marcus Lettau, Michał Zarobkiewicz, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Stimuli‐responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy
Wenhao Xu, Wangrui Liu, Jianfeng Yang, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 181-198
Closed Access | Times Cited: 10
High-dimensional in situ proteomics imaging to assess γδ T cells in spatial biology
Nicola Herold, Matthias Bruhns, Sepideh Babaei, et al.
Journal of Leukocyte Biology (2024) Vol. 115, Iss. 4, pp. 750-759
Closed Access | Times Cited: 3
A self-assembly active nanomodulator based on berberine for photothermal immunotherapy of breast cancer via dual regulation of immune suppression
Jiang Sun, Tingxian Ye, Xinxin Chen, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123898-123898
Closed Access | Times Cited: 3
A radiomics model to predict γδ T‐cell abundance and overall survival in head and neck squamous cell carcinoma
Binna Fan, Binting Fan, Na Sun, et al.
The FASEB Journal (2024) Vol. 38, Iss. 5
Closed Access | Times Cited: 3
Disulfidptosis: A Novel Prognostic Criterion and Potential Treatment Strategy for Diffuse Large B-Cell Lymphoma (DLBCL)
Yu Wang, Yoshiyuki Tsukamoto, Mitsuo Hori, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7156-7156
Open Access | Times Cited: 3
Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3
Jan Schadeck, Hans‐Heinrich Oberg, Matthias Peipp, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 2
A Novel Immune-Related Prognostic Signature Predicting Survival in Patients with Pancreatic Adenocarcinoma
Xiao Zhang, Xiaomian Li, Jun Xie, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-25
Open Access | Times Cited: 9
Bispecific Antibody PD-L1 x CD3 Boosts the Anti-Tumor Potency of the Expanded Vγ2Vδ2 T Cells
Rui Yang, Susu Shen, Cheng Gong, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 12
Vγ2 x PD-L1, a Bispecific Antibody Targeting Both the Vγ2 TCR and PD-L1, Improves the Anti-Tumor Response of Vγ2Vδ2 T Cell
Rui Yang, Qing He, Hui Zhou, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Key players of immunosuppression in epithelial malignancies: Tumor‐infiltrating myeloid cells and γδ T cells
Baishali Tamuli, Sakshi Sharma, Meena Patkar, et al.
Cancer Reports (2024) Vol. 7, Iss. 5
Open Access | Times Cited: 1
Identification of VEGFs-related gene signature for predicting microangiogenesis and hepatocellular carcinoma prognosis
Shengpan Jiang, Guoting Zhu, Yiqing Tan, et al.
Aging (2024) Vol. 16, Iss. 12, pp. 10321-10347
Open Access | Times Cited: 1
Immunotherapy with γδ T-cells: the future is there
Dieter Kabelitz, Zhinan Yin
Immunotherapy (2024) Vol. 16, Iss. 11, pp. 705-708
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top